In Liao et al., a high-throughput sequencing platform called MiSeqTM was utilized to detect hotspot mutations in TP53, TERT, and CTNNB1 in matched ctDNA and tumor samples from 41 patients [104]. The gene discussed is TERT; the disease is neoplasm.